Today, $AKRO announces the pricing of an approximately $350M underwritten public offering of common stock: bit.ly/4ghxjbW

$AKRO announces closing of $402.5 million public offering of common stock, including full exercise of underwriters' option to purchase additional shares: ir.akerotx.com/news-releases/…

This #NationalSelfCheckMonth take a proactive approach to your health! #MASH is often silent in its early stages, which is why it’s vital to stay informed about your risk factors and know when to seek help. Check your risk: brnw.ch/21wQE0I

Tomorrow, our Vice President of Regulatory Affairs, Libette Luce, will be joining Network Partners Group and WIB - Philadelphia to offer speed coaching for women in life sciences. Register today and join this event tomorrow from 6:00-9:00 PM ET: brnw.ch/21wQKLD

Today $AKRO reported Q4 and full year 2024 financial results and provided business updates. Read more at: ir.akerotx.com/news-releases/…

This #NationalNutritionMonth, we want to highlight the critical role diet plays in managing liver health, particularly for individuals living with metabolic diseases like MASH and MASLD. Learn more: liverfoundation.org/health-and-wel…

In honor of #IWD2025 this past weekend, we want to take a moment to recognize the incredible women in science who are shaping the future of healthcare and research. Thank you for continuing to push boundaries, challenge norms, and make a lasting impact in biotech and beyond.

#TeamAkero is heading to NYC this week for the @STATnews 2025 Breakthrough Summit East! Join us on Thursday at 10:55 am ET as our Chief Development Officer, Kitty Yale, speaks at the panel discussion on MASH. Register today: brnw.ch/21wRnwv #STATBreakthrough

Our Chief Development Officer, Kitty Yale, is speaking in a panel today at the STAT 2025 Breakthrough Summit East. Join us at 10:55 am ET as Kitty takes the stage with fellow leaders in the field of MASH to discuss the latest innovations and breakthroughs.

Today, on #WorldHealthDay, we want to highlight the importance of early detection in diseases like #MASLD and #MASH. These conditions can silently impact the liver without presenting noticeable symptoms until it's too late. Prioritize your health by scheduling regular check-ups.

In honor of #WorldLiverDay this past weekend, we’re echoing this year’s theme of food is medicine by sharing some balanced, nutritious recipes to better support liver function. Learn more: worldliverday.org/wp-content/upl…

#TeamAkero will be in Amsterdam next month for the EASLnews Congress 2025. Join us for our 2 oral presentations and a poster presentation highlighting data from our SYMMETRY and HARMONY studies. Register today: events.easl.eu/Home/Index/Eve… #EASLCongress

Honored to be recognized in the EASLnews press release among this year’s top hepatology research. We're presenting the first-ever statistically significant reversal of fibrosis (F4-F3) among patients with compensated cirrhosis caused by MASH Read more: easlcongress.eu/wp-content/upl…

Goedendag from the Netherlands! Today at #EASL25 we shared results from the Phase 2b SYMMETRY study demonstrating the potential of efruxifermin (EFX) to improve fibrosis in compensated cirrhosis (F4) caused by #MASH. Read more: bit.ly/4m5BtHY

$AKRO announced the publication of results from the Phase 2b SYMMETRY study in NEJM. Results support the potential benefit of #EFX to elicit fibrosis improvement in patients with compensated cirrhosis (F4 fibrosis) due to #MASH. Learn more: nejm.org/doi/full/10.10…

#EASL25 is well under way! We’re glad to be in attendance presenting new analyses from our Phase 2b HARMONY study. Don’t miss our oral presentation today at 10:30 CET and stop by our poster anytime between 8:30-16:00 CET to learn more. Read more: ir.akerotx.com/news-releases/…

Today Akero reported Q1 2025 financial results and provided business updates. Read more at: ir.akerotx.com/news-releases/…

Join us tomorrow at the Jefferies Global Healthcare Conference in New York, NY! Can’t make it in person? Tune in to our live corporate presentation tomorrow, June 4th at 8:45 AM ET. Learn more: ir.akerotx.com/news-releases/…

#DYK men are more likely to develop MASLD and MASH early in life? These silent, progressive liver diseases often go undetected until advanced stages. This #MensHealthWeek, we’re calling for more awareness and urging men everywhere to stay up to date with their regular checkups.

This Global #FattyLiverDay, we’re joining the global movement to #ActNowScreenToday. Metabolic diseases such as MASLD and MASH can often go undetected, that’s why early screening is the first step to prevention or intervention. Learn more at fattyliverday.org